Skip to content

Medical emergency? What to do

Parkinson's disease impacts brain's centers of touch and vision

3-RXPublished October 17, 20063 min read

Key points

  • Although Parkinson's disease is most commonly viewed as a "movement disorder," scientists have found that the disease also causes widespread abnormalities in touch and vision Ð effects that have now been verified using functional magnetic resonance imaging (fMRI) of the brain.
  • Sathian's research group studied six patients with moderately advanced PD and six age-matched healthy controls.
  • "Our finding that the visual cortex is affected in Parkinson's disease, while surprising, makes sense given that our laboratory and many others have shown previously that areas of the brain's visual cortex are intimately involved in the sense of touch," Dr.
  • "These problems need to be appreciated in caring for these patients and in designing newer strategies for treatment and rehabilitation," Dr.

Movement disorder affects more than just motor control

Although Parkinson's disease is most commonly viewed as a "movement disorder," scientists have found that the disease also causes widespread abnormalities in touch and vision Ð effects that have now been verified using functional magnetic resonance imaging (fMRI) of the brain. The new findings, by scientists at Emory University School of Medicine and Zhejiang University Medical School in Hangzhou China, will be presented on Oct. 17 at the Society for Neuroscience meeting in Atlanta.

Scientists studying Parkinson's disease (PD) previously have focused on the brain's motor and premotor cortex, but not the somatosensory or the visual cortex. But Emory neurologist Krish Sathian, MD, PhD, and colleagues had earlier discovered, through tests of tactile ability, that PD patients have sensory problems with touch. They designed a study using fMRI to investigate the brain changes underlying these sensory abnormalities.

Dr. Sathian's research group studied six patients with moderately advanced PD and six age-matched healthy controls. After documenting the typical movement problems of PD and ruling out dementia and nerve problems in the PD patients, they administered a common test of tactile ability to both groups, asking the participants to use their fingers to distinguish the orientation of ridges and grooves on plastic gratings. At the same time, they conducted a brain-scanning study using fMRI. This technology measures activations of neurons in different areas of the brain by means of variations in blood flow as an individual does a particular task.

The fMRI scans showed that the PD patients had much less activation of the somatosensory areas in the brain's cortex than did the healthy controls. The scientists also were surprised to find similar widespread differences in the visual cortex, although the task involved touch, not vision.

"Our finding that the visual cortex is affected in Parkinson's disease, while surprising, makes sense given that our laboratory and many others have shown previously that areas of the brain's visual cortex are intimately involved in the sense of touch," Dr. Sathian notes. "Although the reasons for this are uncertain, they may involve a process of mental visualization of the tactile stimuli and may also reflect a multisensory capability of the visual cortex."

Dr. Sathian believes the study shows that the traditional boundaries between brain systems involved in touch and vision, and between those involved in sensation and movement, are artificial constructs that break down with more in-depth study. From a practical standpoint, it shows that patients with PD and other movement disorders have considerable problems in addition to movement control.

"These problems need to be appreciated in caring for these patients and in designing newer strategies for treatment and rehabilitation," Dr. Sathian emphasizes.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underBrain

Keep reading

Brain

New Brain Tumor Vaccine to Be Tested in Humans

For patients with low-grade gliomas, or slow growing brain tumors, a shot in the arm might soon lead to a new treatment therapy. A groundbreaking, first in humans vaccine will be tested in an early phase clinical…

3 min read

Brain

No family link seen between Parkinson's, melanoma

Research has suggested that families affected by melanoma skin cancer may also have a higher-than-average rate of Parkinson's disease -- but a large new study found no evidence of such a link. This doesn't mean no…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.